Previous Close | 56.69 |
1-Year Change | 12.32% |
6-Months Change | 23.03% |
3-Months Change | -3.09% |
Moving Avg (50d) | 57.323 |
Moving Avg (200d) | 50.039 |
ESG Rating | - |
Exchange | NASDAQ |
Market Cap. | 3.35B |
Beta (3-Years) | 1.22 |
Revenue Growth (ttm) | 271.94% |
Net Profit Margin (ttm) | -299.33% |
Return On Assets (ttm) | -52.38% |
EPS (ttm) | -3.24 |
PE Ratio (ttm) | -17.5 |
Dividend Yield | % |
Asset Description: | Rhythm Pharmaceuticals, Inc. |
Predicted Direction: | Sell |
Signal Strength: | Neutral |
Forecast Date: | 2025-02-10 00:00:00 |
Strong Buy | ||
Buy | ||
Neutral | ||
Sell | ||
Strong Sell |
2% | 5% | 7% | 10% | 15% | 20% |
57.824 | 59.524 | 60.658 | 62.359 | 65.193 | 68.028 |
Disclaimer - Please note that the use of AI to analyse contents may occasionally generate incorrect information.
Our cutting-edge algorithms employ macroeconomic data, fundamental and technical analysis indicators to accurately predict the optimal position for short-term trading
By harnessing these signals, we power our asset allocation tools, backtesting tool and portfolio management process, ensuring maximum returns for your investments.
Sector: | Health Care |
Industry: | Biotechnology |
Country: | United States |